Kroes Marijn C W, Schiller Daniela, LeDoux Joseph E, Phelps Elizabeth A
Department of Psychology, Centre for Neural Science, New York University, New York, NY, 10003, USA.
Department of Psychiatry and Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mt. Sinai, New York, NY, 10029, USA.
Curr Top Behav Neurosci. 2016;28:197-230. doi: 10.1007/7854_2015_5008.
Maladaptive learned responses and memories contribute to psychiatric disorders that constitute a significant socio-economic burden. Primary treatment methods teach patients to inhibit maladaptive responses, but do not get rid of the memory itself, which explains why many patients experience a return of symptoms even after initially successful treatment. This highlights the need to discover more persistent and robust techniques to diminish maladaptive learned behaviours. One potentially promising approach is to alter the original memory, as opposed to inhibiting it, by targeting memory reconsolidation. Recent research shows that reactivating an old memory results in a period of memory flexibility and requires restorage, or reconsolidation, for the memory to persist. This reconsolidation period allows a window for modification of a specific old memory. Renewal of memory flexibility following reactivation holds great clinical potential as it enables targeting reconsolidation and changing of specific learned responses and memories that contribute to maladaptive mental states and behaviours. Here, we will review translational research on non-human animals, healthy human subjects, and clinical populations aimed at altering memories by targeting reconsolidation using biological treatments (electrical stimulation, noradrenergic antagonists) or behavioural interference (reactivation-extinction paradigm). Both approaches have been used successfully to modify aversive and appetitive memories, yet effectiveness in treating clinical populations has been limited. We will discuss that memory flexibility depends on the type of memory tested and the brain regions that underlie specific types of memory. Further, when and how we can most effectively reactivate a memory and induce flexibility is largely unclear. Finally, the development of drugs that can target reconsolidation and are safe for use in humans would optimize cross-species translations. Increasing the understanding of the mechanism and limitations of memory flexibility upon reactivation should help optimize efficacy of treatments for psychiatric patients.
适应不良的习得反应和记忆会导致构成重大社会经济负担的精神疾病。主要治疗方法教导患者抑制适应不良的反应,但并未消除记忆本身,这就解释了为什么许多患者即使在最初治疗成功后仍会出现症状复发。这凸显了发现更持久、更有效的技术来减少适应不良的习得行为的必要性。一种潜在有前景的方法是通过针对记忆再巩固来改变原始记忆,而不是抑制它。最近的研究表明,重新激活旧记忆会导致一段时间的记忆灵活性,并且需要重新存储或再巩固才能使记忆持续存在。这个再巩固期为修改特定的旧记忆提供了一个窗口。重新激活后记忆灵活性的恢复具有巨大的临床潜力,因为它能够针对再巩固并改变导致适应不良心理状态和行为的特定习得反应和记忆。在这里,我们将回顾针对非人类动物、健康人类受试者和临床人群的转化研究,这些研究旨在通过使用生物治疗(电刺激、去甲肾上腺素能拮抗剂)或行为干扰(重新激活-消退范式)来针对再巩固改变记忆。这两种方法都已成功用于修改厌恶和食欲记忆,但在治疗临床人群方面的有效性有限。我们将讨论记忆灵活性取决于所测试的记忆类型以及特定类型记忆所依赖的脑区。此外,我们何时以及如何最有效地重新激活记忆并诱导灵活性在很大程度上尚不清楚。最后,开发能够针对再巩固且对人类使用安全的药物将优化跨物种转化。增加对重新激活时记忆灵活性的机制和局限性的理解应有助于优化对精神科患者的治疗效果。